Market Overview:
The global bilirubin colorimeter assay market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of jaundice, rising demand for point-of-care testing, and technological advancements in bilirubin colorimeters. On the basis of type, the global bilirubin colorimeter assay market is segmented into conjugated bilirubin (direct bilirubin) and unconjugated bilirubin (indirect bilirubin).
Product Definition:
A bilirubin colorimeter assay is a clinical diagnostic test that is used to measure the level of bilirubin in the blood. Bilirubin is a yellow-green pigment that is produced when red blood cells break down. A high level of bilirubin can indicate a problem with the liver or gallbladder. The bilirubin colorimeter assay is an important test for assessing the health of these organs.
Conjugated Bilirubin (Direct Bilirubin):
Conjugated bilirubin is a chemical that occurs naturally in the body. The normal range for conjugated bilirubin level in human blood is 0.4 - 5.6 mg/L and it fluctuates within an acceptable range according to the individual’s health conditions and medications taken by them.
Unconjugated Bilirubin (Indirect Bilirubin):
Unconjugated bilirubin is the first pass metabolism product of bilirubin that remains in the blood. It has a wide range of applications in clinical chemistry and it can be used to detect various diseases related to liver, such as jaundice, hepatitis, and others. Unconjugated Bilirubin is also known as Direct Bilirubin or Direct Red Blood Cell (D RBC) Chloride Shift Test (DBSCT).
Application Insights:
The market is segmented into hospitals, clinics, diagnostic laboratories and others. The hospitals segment dominated the global market in 2017 owing to increasing awareness about jaundice and rising number of neonates suffering from hyperbilirubinemia. Increasing prevalence of chronic liver diseases such as non-alcoholic Steatohepatitis (NASH) and alcoholic liver disease (ALD) has also driven the growth of this segment. NASH accounts for a significant proportion of patients with chronic liver diseases worldwide; it is estimated that over 90% patients with NASH will develop cirrhosis in 5 years if treatment is not initiated. Thus, rising incidence rates coupled with a high mortality rate are driving demand for bilirubin colorimeter assay devices in hospital settings across the globe.
Regional Analysis:
North America dominated the global market in 2017. The presence of well-established healthcare infrastructure, high adoption rate of technologically advanced products and increased focus on newborn screening programs are some factors responsible for the large share held by this region. Moreover, a rise in demand for blood bilirubin tests is anticipated to drive regional growth over the forecast period.
Asia Pacific is expected to witness lucrative growth during the forecast period owing to an increase in healthcare expenditure and awareness campaigns regarding neonatal jaundice conducted by various organizations such as WHO & UNICEF and government agencies. In addition, increasing incidence of congenital disorders due to changing lifestyle habits such as smoking or alcohol consumption among women coupled with an aging population will drive regional growth over the forecast period.
Growth Factors:
- Increasing incidence of jaundice and other liver diseases
- Growing demand for point-of-care diagnostics
- Technological advancements in bilirubin colorimeter assay market
- Rising awareness about early diagnosis and treatment of liver diseases
- Increasing number of collaborations and partnerships between diagnostic companies and research institutes
Scope Of The Report
Report Attributes
Report Details
Report Title
Bilirubin Colorimeter Assay Market Research Report
By Type
Conjugated Bilirubin (Direct Bilirubin), Unconjugated Bilirubin (Indirect Bilirubin)
By Application
Hospitals, Clinics, Diagnostic Laboratories, Other
By Companies
Cell Biolabs, Sigma-Aldrich, Tulip Diagnostics, Euro Diagnostic Systems, Excel Diagnostics, Express Biotech International, Siemens Healthcare Diagnostics, BioVision, Abbott Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Bilirubin Colorimeter Assay Market Report Segments:
The global Bilirubin Colorimeter Assay market is segmented on the basis of:
Types
Conjugated Bilirubin (Direct Bilirubin), Unconjugated Bilirubin (Indirect Bilirubin)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Diagnostic Laboratories, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Cell Biolabs
- Sigma-Aldrich
- Tulip Diagnostics
- Euro Diagnostic Systems
- Excel Diagnostics
- Express Biotech International
- Siemens Healthcare Diagnostics
- BioVision
- Abbott Laboratories
Highlights of The Bilirubin Colorimeter Assay Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Conjugated Bilirubin (Direct Bilirubin)
- Unconjugated Bilirubin (Indirect Bilirubin)
- By Application:
- Hospitals
- Clinics
- Diagnostic Laboratories
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bilirubin Colorimeter Assay Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The bilirubin colorimeter assay is a blood test that measures the level of bilirubin in a person's blood. Bilirubin is a byproduct of the breakdown of red blood cells. The higher the level of bilirubin, the more serious the condition may be.
Some of the major players in the bilirubin colorimeter assay market are Cell Biolabs, Sigma-Aldrich, Tulip Diagnostics, Euro Diagnostic Systems, Excel Diagnostics, Express Biotech International, Siemens Healthcare Diagnostics, BioVision, Abbott Laboratories.
The bilirubin colorimeter assay market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Bilirubin Colorimeter Assay Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Bilirubin Colorimeter Assay Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Bilirubin Colorimeter Assay Market - Supply Chain
4.5. Global Bilirubin Colorimeter Assay Market Forecast
4.5.1. Bilirubin Colorimeter Assay Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Bilirubin Colorimeter Assay Market Size (000 Units) and Y-o-Y Growth
4.5.3. Bilirubin Colorimeter Assay Market Absolute $ Opportunity
5. Global Bilirubin Colorimeter Assay Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Bilirubin Colorimeter Assay Market Size and Volume Forecast by Type
5.3.1. Conjugated Bilirubin (Direct Bilirubin)
5.3.2. Unconjugated Bilirubin (Indirect Bilirubin)
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Bilirubin Colorimeter Assay Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Bilirubin Colorimeter Assay Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Diagnostic Laboratories
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Bilirubin Colorimeter Assay Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Bilirubin Colorimeter Assay Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Bilirubin Colorimeter Assay Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Bilirubin Colorimeter Assay Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Bilirubin Colorimeter Assay Demand Share Forecast, 2019-2026
9. North America Bilirubin Colorimeter Assay Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Bilirubin Colorimeter Assay Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Bilirubin Colorimeter Assay Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Diagnostic Laboratories
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Bilirubin Colorimeter Assay Market Size and Volume Forecast by Type
9.7.1. Conjugated Bilirubin (Direct Bilirubin)
9.7.2. Unconjugated Bilirubin (Indirect Bilirubin)
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Bilirubin Colorimeter Assay Demand Share Forecast, 2019-2026
10. Latin America Bilirubin Colorimeter Assay Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Bilirubin Colorimeter Assay Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Bilirubin Colorimeter Assay Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Diagnostic Laboratories
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Bilirubin Colorimeter Assay Market Size and Volume Forecast by Type
10.7.1. Conjugated Bilirubin (Direct Bilirubin)
10.7.2. Unconjugated Bilirubin (Indirect Bilirubin)
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Bilirubin Colorimeter Assay Demand Share Forecast, 2019-2026
11. Europe Bilirubin Colorimeter Assay Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Bilirubin Colorimeter Assay Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Bilirubin Colorimeter Assay Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Diagnostic Laboratories
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Bilirubin Colorimeter Assay Market Size and Volume Forecast by Type
11.7.1. Conjugated Bilirubin (Direct Bilirubin)
11.7.2. Unconjugated Bilirubin (Indirect Bilirubin) 11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Bilirubin Colorimeter Assay Demand Share, 2019-2026
12. Asia Pacific Bilirubin Colorimeter Assay Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Bilirubin Colorimeter Assay Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Bilirubin Colorimeter Assay Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Diagnostic Laboratories
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Bilirubin Colorimeter Assay Market Size and Volume Forecast by Type
12.7.1. Conjugated Bilirubin (Direct Bilirubin)
12.7.2. Unconjugated Bilirubin (Indirect Bilirubin)
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Bilirubin Colorimeter Assay Demand Share, 2019-2026
13. Middle East & Africa Bilirubin Colorimeter Assay Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Bilirubin Colorimeter Assay Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Bilirubin Colorimeter Assay Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Diagnostic Laboratories
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Bilirubin Colorimeter Assay Market Size and Volume Forecast by Type
13.7.1. Conjugated Bilirubin (Direct Bilirubin)
13.7.2. Unconjugated Bilirubin (Indirect Bilirubin)
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Bilirubin Colorimeter Assay Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Bilirubin Colorimeter Assay Market: Market Share Analysis
14.2. Bilirubin Colorimeter Assay Distributors and Customers
14.3. Bilirubin Colorimeter Assay Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Cell Biolabs
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Sigma-Aldrich
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Tulip Diagnostics
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Euro Diagnostic Systems
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Excel Diagnostics
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Express Biotech International
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Siemens Healthcare Diagnostics
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. BioVision
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Abbott Laboratories
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
